Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382987576> ?p ?o ?g. }
- W4382987576 abstract "Abstract Background Abnormal activation of NLRP3 inflammasome is related to a series of inflammatory diseases, including type 2 diabetes, gouty arthritis, non-alcoholic steatohepatitis (NASH), and neurodegenerative disorders. Therefore, targeting NLRP3 inflammasome is regarded as a potential therapeutic strategy for many inflammatory diseases. A growing number of studies have identified tanshinone I (Tan I) as a potential anti-inflammatory agent because of its good anti-inflammatory activity. However, its specific anti-inflammatory mechanism and direct target are unclear and need further study. Methods IL-1β and caspase-1 were detected by immunoblotting and ELISA, and mtROS levels were measured by flow cytometry. Immunoprecipitation was used to explore the interaction between NLRP3, NEK7 and ASC. In a mouse model of LPS-induced septic shock, IL-1β levels in peritoneal lavage fluid and serum were measured by ELISA. Liver inflammation and fibrosis in the NASH model were analyzed by HE staining and immunohistochemistry. Results Tan I inhibited the activation of NLRP3 inflammasome in macrophages, but had no effect on the activation of AIM2 or NLRC4 inflammasome. Mechanistically, Tan I inhibited NLRP3 inflammasome assembly and activation by targeting NLRP3-ASC interaction. Furthermore, Tan I exhibited protective effects in mouse models of NLRP3 inflammasome-mediated diseases, including septic shock and NASH. Conclusions Tan I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC, and exhibits protective effects in mouse models of LPS-induced septic shock and NASH. These findings suggest that Tan I is a specific NLRP3 inhibitor and may be a promising candidate for treating NLRP3 inflammasome-related diseases. Graphical Abstract" @default.
- W4382987576 created "2023-07-04" @default.
- W4382987576 creator A5007362555 @default.
- W4382987576 creator A5007469178 @default.
- W4382987576 creator A5007919131 @default.
- W4382987576 creator A5018256092 @default.
- W4382987576 creator A5022017788 @default.
- W4382987576 creator A5029555016 @default.
- W4382987576 creator A5031861788 @default.
- W4382987576 creator A5033097552 @default.
- W4382987576 creator A5035637457 @default.
- W4382987576 creator A5039213269 @default.
- W4382987576 creator A5044845635 @default.
- W4382987576 creator A5045423783 @default.
- W4382987576 creator A5046732056 @default.
- W4382987576 creator A5048498718 @default.
- W4382987576 creator A5067338637 @default.
- W4382987576 creator A5070759638 @default.
- W4382987576 creator A5076863688 @default.
- W4382987576 creator A5087113734 @default.
- W4382987576 creator A5089074556 @default.
- W4382987576 date "2023-07-03" @default.
- W4382987576 modified "2023-10-18" @default.
- W4382987576 title "Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC" @default.
- W4382987576 cites W1985538633 @default.
- W4382987576 cites W1987329700 @default.
- W4382987576 cites W2019024302 @default.
- W4382987576 cites W2028017703 @default.
- W4382987576 cites W2037600884 @default.
- W4382987576 cites W2042816890 @default.
- W4382987576 cites W2065788317 @default.
- W4382987576 cites W2068633454 @default.
- W4382987576 cites W2079882002 @default.
- W4382987576 cites W2081262717 @default.
- W4382987576 cites W2118918019 @default.
- W4382987576 cites W2124178650 @default.
- W4382987576 cites W2135450217 @default.
- W4382987576 cites W2136354950 @default.
- W4382987576 cites W2169624083 @default.
- W4382987576 cites W2206076053 @default.
- W4382987576 cites W2210680772 @default.
- W4382987576 cites W2253667517 @default.
- W4382987576 cites W2254807163 @default.
- W4382987576 cites W2346799309 @default.
- W4382987576 cites W2462773201 @default.
- W4382987576 cites W2585046292 @default.
- W4382987576 cites W2713544237 @default.
- W4382987576 cites W2773720435 @default.
- W4382987576 cites W2790572647 @default.
- W4382987576 cites W2810072585 @default.
- W4382987576 cites W2884445384 @default.
- W4382987576 cites W2889938393 @default.
- W4382987576 cites W2897382070 @default.
- W4382987576 cites W2912208837 @default.
- W4382987576 cites W2915366056 @default.
- W4382987576 cites W2915617311 @default.
- W4382987576 cites W2943293743 @default.
- W4382987576 cites W2954782052 @default.
- W4382987576 cites W2979337403 @default.
- W4382987576 cites W2981732606 @default.
- W4382987576 cites W2995859967 @default.
- W4382987576 cites W3004419980 @default.
- W4382987576 cites W3016264847 @default.
- W4382987576 cites W3017375711 @default.
- W4382987576 cites W3018715435 @default.
- W4382987576 cites W3026716702 @default.
- W4382987576 cites W3033880725 @default.
- W4382987576 cites W3048159287 @default.
- W4382987576 cites W3080901962 @default.
- W4382987576 cites W3114931192 @default.
- W4382987576 cites W3114991225 @default.
- W4382987576 cites W3127748047 @default.
- W4382987576 cites W3132352839 @default.
- W4382987576 cites W3152939216 @default.
- W4382987576 cites W3172555728 @default.
- W4382987576 cites W3184419369 @default.
- W4382987576 cites W3201140523 @default.
- W4382987576 cites W3207130419 @default.
- W4382987576 cites W4205925070 @default.
- W4382987576 cites W4213186208 @default.
- W4382987576 cites W4214844457 @default.
- W4382987576 cites W4220782002 @default.
- W4382987576 cites W4288748435 @default.
- W4382987576 cites W4294215738 @default.
- W4382987576 cites W4294668058 @default.
- W4382987576 cites W4307799299 @default.
- W4382987576 cites W4311504937 @default.
- W4382987576 doi "https://doi.org/10.1186/s10020-023-00671-0" @default.
- W4382987576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37400760" @default.
- W4382987576 hasPublicationYear "2023" @default.
- W4382987576 type Work @default.
- W4382987576 citedByCount "0" @default.
- W4382987576 crossrefType "journal-article" @default.
- W4382987576 hasAuthorship W4382987576A5007362555 @default.
- W4382987576 hasAuthorship W4382987576A5007469178 @default.
- W4382987576 hasAuthorship W4382987576A5007919131 @default.
- W4382987576 hasAuthorship W4382987576A5018256092 @default.
- W4382987576 hasAuthorship W4382987576A5022017788 @default.
- W4382987576 hasAuthorship W4382987576A5029555016 @default.
- W4382987576 hasAuthorship W4382987576A5031861788 @default.